Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
3 Thoughts on the FDA’s Final LDTs Rule
Regulatory expert Julie Ballard shares her first thoughts on the final rule for lab-developed tests and immediate steps for labs
CMS Offers New Guidance on Medicare E-Signature Rules
Failure to comply with Medicare signature and authentication rules is a frequent cause of claims denials. In January, CMS revised its Medicare signature guidelines to incorporate new rules for electronic signatures. Acceptable signatures include handwritten...
Partnership to Accelerate SARS-CoV-2 Variant Identification in the US
On March 23, Thermo Fisher Scientific announced it is partnering with population genomics company Helix, bioinformatics company Rosalind, and the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative to identify SARS-CoV-2 variants...
MedPAC to Congress: Don’t Raise Physician Medicare Pay in 2023
There’s no compelling reason to pay physicians more next year, concludes the 604-page report that the Medicare Payment Assessment Commission (MedPAC) submitted to Congress on March 15. “We expect volume and revenue to return to pre-pandemic levels (or higher) by...
FDA Releases Recommendations for Safe Use of At-Home COVID-19 Tests
On March 18, the U.S. Food and Drug Administration (FDA) released a Safety Communication about the dangers of improperly used FDA authorized at-home COVID-19 tests. The agency also reminded the public that these tests should be safely stored away from children and...
Labs in Court Weekly Roundup
Enforcement actions involving health care fraud were again dominant over the past two weeks, based on information from the U.S. Department of Justice (DOJ) and state agencies. Of the key court cases involving the lab and/or health care industry from March 10-21,...
Fraud Trial of Theranos CEO Is Back on Track
After several delays, the trial of former Theranos CEO Ramesh "Sunny" Balwani on charges of fraud and wire fraud resumes today. The prosecution evidence includes records showing that Theranos voided lab test results to cure CLIA deficiencies cited in January 2016....
MRI Innovation Makes Cancerous Tissue Light Up and Easier to See
A new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could help doctors more accurately detect and track the progression of cancer over time. The innovation, developed by researchers at the University of Waterloo,...
Saliva Testing for COVID-19 Quicker, Safer than Nasal Swabs
WASHINGTON, DC — Genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing of nasal swabs, according to research published March 21 in Microbiology Spectrum, a journal of the American Society for Microbiology. “That is important...
New Assay Could Make Allergy Testing Easier and Less Painful
Diagnosing allergies is difficult and cumbersome. Current skin-prick tests are painful, time-consuming, and carry the chance of the patient having a dangerous allergic reaction. But a new assay from researchers at the University of Bern and Inselspital, Bern...
NIH Sees Budget Increase by $2 Billion
On March 15, President Biden signed the Consolidated Appropriations Act, 2022 into law, an omnibus bill that sets the budgets for all federal agencies for the rest of FY2022. The bill includes a $2 billion increase for the National Institutes of Health (NIH),...
